Vasculitis and Giant Cell Arteritis News

Patients with ANCA-associated vasculitis who have a history of autoimmune disease prior to diagnosis may have fewer relapses following remission, according to data published in Clinical and Experimental Rheumatology.

Rheumatologists should assess for PR3- and MPO-ANCA using a “high-quality antigen-specific assay” as the primary testing method for patients suspected of ANCA-associated vasculitis, according to updated EULAR recommendations.

Cases of Kawasaki disease dropped 28% during the COVID-19 pandemic and remained low following implementation of prevention efforts, including mask mandates and school closures, according to data published in JAMA Network Open.

Patients with systemic autoimmune rheumatic disorders who show evidence of illness-related uncertainty also tend to experience depression, anxiety and increased sickness impact, according to data published in the Journal of Rheumatology.

CLEVELAND — In this video, Robert G. Micheletti, MD, associate professor of dermatology and medicine and chief of hospital dermatology at the University of Pennsylvania, discusses updates in vasculitis evaluation and treatment.

During Vasculitis Awareness Month in May, patient advocacy organizations face the challenge of raising awareness for a rare disease with many different manifestations and states.

DESTIN, Fla. — Treatments for rare complications in vasculitis can range from high-dose prednisone to nasal lavage, according to a speaker at the Congress of Clinical Rheumatology East.

Children and adolescents with rheumatic and musculoskeletal diseases who contract COVID-19 are not likely to require hospitalization, according to data published in the Annals of the Rheumatic Diseases.

March is Autoimmune Awareness Month, and rheumatology organizations have been using their reach and influence on social media sites to spread the word and help patients with autoimmune diseases find community.

Glucocorticoids can do a lot of harm over time. In this episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over time that we’ll be seeing more of in the future.